Summary
- Current Price
- As of today, SGP price is $19.26, down -2.92% on
- Current Price All-Time High
- SGP price is currently -40.63% below its historical high of $32.44 set on
- Market Cap
- SGP current market cap is $644M, with unknown 1-year change
- PE Ratio
- SGP PE ratio is unknown
- Revenue
- SGP current annual revenue is $0.00, with unknown 1-year change
- Next Earnings
- The next earnings release for SGP is on
Profile
| Metric | Value |
|---|---|
| Full Name | SpyGlass Pharma, Inc. |
| Ticker | NASDAQ: SGP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | spyglasspharma.com |
| Employees | 1,489 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $19.26 | |
| Price, 1D Change | -2.92% | |
| $644M | ||
| - | ||
| - | ||
| 1.78 | ||
| $0 | ||
| Revenue, 1Y Change | - | |
| -$1.19 | ||
| EPS, 1Y Change | -100.00% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.19 | ||
| EPS Estimate | N/A | -$2.31 |
| EPS Est. Change | N/A | -93.95% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $19.26 | |
| Price Target | - | $42.00 |
| Price Tgt. Change | - | +118.07% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.03 | -$1.19 | +41.12% | |
| -$2.31 | N/A | -93.95% | |
| -$2.70 | N/A | -126.13% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $19.26 | |
| $24.87 | ||
| SMA 200 vs Price | +29.12% | |
| $23.37 | ||
| SMA 50 vs Price | +21.32% | |
| 1.78 | ||
| $1.59 | ||
| 30.65 | ||
| 42.99% | ||
| 63.65% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.19 | ||
| -$612.00K | ||
| - | ||
| -$41.45M | ||
| - | ||
| -$39.87M | ||
| - | ||
| -$40.84M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 12.67 | ||
| 12.67 | ||
| - | ||
| - | ||
| 34.95 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 2.57 | ||
| -13.84 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$98.84M | ||
| $107.44M | ||
| $116.33M | ||
| $108.77M | ||
| $10.63M | ||
| $8.58M | ||
| $1.58M | ||
| $0.00 | ||
| $2.70M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $39.87M | ||
| $40.84M | ||
| $612.00K | ||
| $0.00 | ||
| $612.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$32.70M | ||
| -$11.79M | ||
| $124.59M | ||
| $789.00K | ||
| -$33.49M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | ||
| Stifel | ||
| Leerink Partners | ||
| Jefferies | ||
| Citigroup |
Analyst sentiment
Institutional ownership
Screeners with SGP
FAQ
What is the ticker symbol for SpyGlass Pharma, Inc.?
The ticker symbol for SpyGlass Pharma, Inc. is NASDAQ:SGP
Does SpyGlass Pharma, Inc. pay dividends?
No, SpyGlass Pharma, Inc. does not pay dividends
What sector is SpyGlass Pharma, Inc. in?
SpyGlass Pharma, Inc. is in the Healthcare sector
What industry is SpyGlass Pharma, Inc. in?
SpyGlass Pharma, Inc. is in the Biotechnology industry
What country is SpyGlass Pharma, Inc. based in?
SpyGlass Pharma, Inc. is headquartered in United States
When did SpyGlass Pharma, Inc. go public?
SpyGlass Pharma, Inc. initial public offering (IPO) was on January 8, 2008
Is SpyGlass Pharma, Inc. in the S&P 500?
No, SpyGlass Pharma, Inc. is not included in the S&P 500 index
Is SpyGlass Pharma, Inc. in the NASDAQ 100?
No, SpyGlass Pharma, Inc. is not included in the NASDAQ 100 index
Is SpyGlass Pharma, Inc. in the Dow Jones?
No, SpyGlass Pharma, Inc. is not included in the Dow Jones index
When was SpyGlass Pharma, Inc. last earnings report?
SpyGlass Pharma, Inc.'s most recent earnings report was on May 14, 2026
When does SpyGlass Pharma, Inc. report earnings?
The next expected earnings date for SpyGlass Pharma, Inc. is August 31, 2026
Data Sources & References
- SGP Official Website www.spyglasspharma.com
- SGP Profile on Yahoo Finance finance.yahoo.com/quote/SGP
- SGP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sgp